Abstract Four hitherto unknown polysubstituted isoflavonoids, including three isoflavans: 7,4 0 -dihydroxy-8,2 0 ,3 0 -trimethoxyisoflavan (1), 7,2 0 ,4 0 -trihydroxy-8,3 0 -dimethoxyisoflavan (2), and 7,2 0 ,4 0 -trihydroxy-5-methoxyisoflavan (3), and one prenylated isoflavone cudraisoflavone M (4) were isolated from the ethanol extracts of Spatholobus suberectus (for 1 and 2), Flemingia macrophylla (for 3), and Cudrania cochinchinensis (for 4), respectively. Their structures were established on the basis of extensive spectroscopic analysis. Compounds 1 and 4 exhibited weak cytotoxic activity against five human cancer cell lines (HL-60, A-549, SMMC-7721, MCF-7, and SW-480). Graphical Abstract
macrophylla (Leguminosae), and Cudrania cochinchinensis (Moraceae) led to the isolation of three new isoflavans 7, 4 0 -dihydroxy-8,2 0 ,3 0 -trimethoxyisoflavan (1), 7,2 0 ,4 0 -trihydroxy-8,3
0 -dimethoxyisoflavan (2), and 7,2 0 ,4 0 -trihydroxy-5-methoxyisoflavan (3), and one new prenylated isoflavone namely cudraisoflavone M (4), respectively ( Fig. 1) . Herein we report the structure elucidation of new isoflavonoid and their cytotoxicity evaluation against five human cancer cell lines (HL-60, A-549, SMMC-7721, MCF-7, and SW-480).
Results and Discussion
Compound 1 was obtained as white amorphous powder, and its molecular formula was determined to be C 18 (Fig. 2) . Hence, the structure of 2 was established as 7,2 0 ,4 0 -trihydroxy-8,3
0 -dimethoxyisoflavan. Compound 3 was isolated as white amorphous powder, and its molecular formula was determined to be C 16 Fig. 2) . Therefore, the structure of 3 was established as 7,2 0 ,4 0 -trihydroxy-5-methoxyisoflavan. Absolute configurations of the isoflavans (1-3) were established by comparison of the CD curves with those reported earlier for closely related analogues. All the CD spectra showed a negative Cotton effect in the transition region (215-240 nm), similar with those of 7-O-methylisomucronulatol, (3R)-isomucronulatol, and abruquinone L [16] [17] [18] [19] , which indicated the absolute configurations at C-3 of 1-3 being R-form. And optical rotation measurements were also taken to assign the absolute configuration. We carefully examined the specific rotation (Table 3) , and the results suggested that the methoxy group substituted at C-2 0 had a huge impact on the specific rotation, probably on account of the spatial proximity. For 2 0 -methoxyisoflavans, R-/S-form result in positive/negative specific rotation values, respectively, but for 2 0 -hydroxyisoflavans, R-form gives negative values [14, 17, [20] [21] [22] [23] [24] [25] . Our current research results were consistent with the above empirical rule.
Compound 4, yellowish amorphous powder, had a molecular formula of C 22 8.23 ) to C-9 (d C 154.6). Thus the structure of 4 was established and named as cudraisoflavone M. It is worth mentioning that cudraisoflavone M (4) was also obtained in our phytochemical investigation on the plant Derris robusta (Leguminosae). 
(s)
Considering the potent cytotoxic activity of some isoflavonoids, the cytotoxicity of these new isoflavonoids (1-4) was evaluated against five human cancer cell lines (HL-60, A-549, SMMC-7721, MCF-7, and SW-480) using the MTS method. DDP (cisplatin) and paclitaxel were used as positive controls. The results showed that 1 and 4 exhibited weak cytotoxic activity (Table 5) 
General Experimental Procedures
Optical rotations were measured on Jasco P-1020 automatic digital polarimeter. CD spectra were recorded on a Chirascan spectropolarimeter (Applied Photophysics, Leatherhead, Surrey, UK). UV data were obtained from HPLC online analysis. IR spectra were obtained on a Bruker Tensor-27 infrared spectrophotometer with KBr pellets. NMR spectra were carried out on a Bruker Avance III 600 or DRX-500 spectrometer with deuterated solvent signals used as internal standards. ESIMS and HRESIMS were measured using Agilent G6230 time-of-flight mass spectrometer. Preparative MPLC was performed on a Büchi apparatus equipped with Büchi fraction collector C-660, Büchi pump module C-605 and manager C-615. Silica gel (200-300 mesh, Qingdao Marine Chemical Inc., China), MCI gel CHP-20P (75-150 lm, Mitsubishi Chemical Corporation, Japan), Chromatorex C-18 (40-75 lm, Fuji Silysia Chemical Ltd., Japan) and Sephadex LH-20 (GE Healthcare Bio-Sciences AB, Uppsala, Sweden) were used for column chromatography. Fractions were monitored and analyzed using TLC, in combination with an Agilent 1200 series HPLC system equipped by an Extend-C18 column (5 lm, 4.6 9 150 mm). (Table 6) The retention times (t R ) of 1-4 on an analytical HPLC Extend-C18 column (20% ? 100% MeOH in H 2 O over 8.0 min followed by 100% MeOH to 13.0 min, 1.0 mL/ min, 25°C) were 7.51, 6.85, 6.61 and 9.12 min, respectively. 
Plant Material and Isolation

Cytotoxicity Assays
Five human tumor cell lines (HL-60, A-549, SMMC-7721, MCF-7, and SW-480) obtained from ATCC (Manassas, VA, USA) were used in the cytotoxicity assay. All cells were cultured in RPMI-1640 or DMEM medium (Hyclone, Logan, UT, USA), supplemented with 10% fetal bovine serum (Hyclone) at 37°C in a humidified atmosphere containing 5% CO 2 . Cell viability was assessed by conducting colorimetric measurements of the amount of insoluble formazan formed in living cells based on the reduction of MTS (Sigma, St. Louis, MO, USA). Briefly, 100 lL of adherent cells were seeded into each well of a 96-well cell culture plate and allowed to adhere for 12 h before drug addition, while suspended cells were seeded just before drug addition, both with an initial density of 1 9 10 5 cells/mL in 100 lL medium. Each cell line was exposed to the test compound at various concentrations in triplicate for 48 h, with cisplatin and paclitaxel as positive controls. After the incubation, 20 lL MTS and 100 lL medium was added to each well after removal of 100 lL medium, and the incubation continued for 2-4 h at 37°C. The optical density was measured at 492 nm using a Multiskan FC plate reader (Thermo Scientific, USA). The IC 50 value of each compound was calculated according to the Reed and Muench method.
